Dampened Reactive Hematopoiesis and Systemic Inflammatory Response Following Early Recurrent Myocardial Infarction in Mice.
Acute myocardial infarction (AMI) impacts the regenerative capacity of hematopoietic stem and progenitor cells (HSPCs) following injury, but it remains unclear if these functional alterations persist beyond the initial ischemic event.A minimally invasive mouse model of recurrent myocardial infarction was established using echocardiography-guided coronary interventions. Bone marrow HSPCs were quantified and analyzed for proliferation by flow cytometry and BrdU incorporation. Peripheral blood leukocytes and inflammatory cytokines (IL-6, G-CSF) were measured by flow cytometry and ELISA. Bone marrow extracellular TGF-β1 was assessed by ELISA, and its functional role was evaluated through antibody-mediated inhibition.The minimally invasive infarction model was validated through electrocardiography, cardiac biomarkers, echocardiography, and cardiac pathology staining. Fourteen days post-I/R or sham treatment, bone marrow hematopoiesis returned to a steady state with no significant differences in Lin-Sca-1+c-Kit+ (LSK), hematopoietic stem cell (HSC), multipotent progenitor (MPP), and granulocyte/macrophage progenitor (GMP) cell numbers. However, after a secondary ischemic challenge, there was a dampened reactive hematopoiesis indicated by reduced HSPCs, compared to the first ischemic event. BrdU incorporation analysis showed decreased HSPC proliferation activity during the reparative phase after initial ischemic challenge, linking dampened hematopoiesis to decreased HSPCs proliferation. Additionally, early recurrent infarct mice had fewer neutrophils released in peripheral blood and lower serum IL-6 and G-CSF levels. Elevated TGF-β1 levels were detected in bone marrow extracellular fluid during the reparative phase of cardiac-ischemic injury, and inhibiting TGF-β1 reversed the dampened reactive hematopoiesis of HSPCs in an early recurrent MI setting.Our data suggest that initial myocardial ischemia challenges blunt bone marrow reactive hematopoiesis to subsequent ischemic stress, with decreased HSPC proliferation contributing to diminished regenerative capacity. TGF-β1 in bone marrow extracellular fluid may mediate this decreased HSPC proliferation.
- # Hematopoietic Stem And Progenitor Cells
- # Bone Marrow Extracellular Fluid
- # Hematopoietic Stem Cell
- # Bone Marrow Hematopoietic Stem And Progenitor Cells
- # Early Recurrent Myocardial Infarction
- # Progenitor Cell
- # Early Recurrent Infarction
- # Lower Serum IL-6
- # Recurrent Infarction
- # Elevated TGF-β1 Levels
- Research Article
49
- 10.1016/j.stem.2020.09.004
- Sep 29, 2020
- Cell stem cell
MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia.
- Research Article
93
- 10.1016/j.exphem.2006.03.016
- Jul 22, 2006
- Experimental Hematology
The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization
- Abstract
- 10.1182/blood.v122.21.587.587
- Nov 15, 2013
- Blood
Hematopoietic Stem Cells and Their BM Stromal Microenvironment Share a Dynamic Inverse Metabolic State During Quiescence and Proliferation Via ROS Transfer Between The Two Populations
- Research Article
127
- 10.1016/j.exphem.2006.04.005
- Jul 22, 2006
- Experimental Hematology
Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails the cells that make blood and bone
- Research Article
103
- 10.1016/j.stemcr.2013.07.004
- Aug 15, 2013
- Stem Cell Reports
Transcriptome Analysis Identifies Regulators of Hematopoietic Stem and Progenitor Cells
- Abstract
7
- 10.1182/blood.v128.22.5.5
- Dec 2, 2016
- Blood
Mitochondria Transfer from Hematopoietic Stem and Progenitor Cells to Pdgfrα+/Sca-1-/CD48dim BM Stromal Cells Via CX43 Gap Junctions and AMPK Signaling Inversely Regulate ROS Generation in Both Cell Populations
- Abstract
- 10.1182/blood-2018-99-118354
- Nov 29, 2018
- Blood
Nocturnal Melatonin Renews Bone and Blood Forming Stem Cells Reservoir By Metabolic Reprograming
- Abstract
1
- 10.1182/blood.v128.22.3370.3370
- Dec 2, 2016
- Blood
Inverse PAR1 Activity of Hematopoietic Stem Cells and BM Stromal Cells Mediates G-CSF-Induced Mobilization By Regulation of Nitric Oxide Generation
- Abstract
- 10.1182/blood.v122.21.217.217
- Nov 15, 2013
- Blood
Blood Cell Replenishment and Bone Marrow Stem Cell Pool Renewal Are Regulated By Different Circadian Peaks Via Norepinephrine and TNFα/S1P Signaling
- Research Article
38
- 10.1016/j.exphem.2011.10.009
- Nov 13, 2011
- Experimental Hematology
On the symmetry of siblings: automated single-cell tracking to quantify the behavior of hematopoietic stem cells in a biomimetic setup
- Abstract
2
- 10.1182/blood.v124.21.771.771
- Dec 6, 2014
- Blood
PGE2 Promotes BM Hematopoietic Stem Cell Retention Via Stromal Lactate Production, cAMP and CXCL12/CXCR4 Regulation
- Abstract
2
- 10.1182/blood-2023-189964
- Nov 2, 2023
- Blood
High Mobility Group A1 Chromatin Regulators Drive Regenerative Capacity during Stress Hematopoiesis through Modulation of TNF-α and Aging Transcriptional Networks
- Research Article
11
- 10.1016/j.exphem.2016.05.002
- May 13, 2016
- Experimental Hematology
Hematopoietic stem cell-specific GFP-expressing transgenic mice generated by genetic excision of a pan-hematopoietic reporter gene.
- Research Article
- 10.1182/blood-2024-204131
- Nov 5, 2024
- Blood
Multimodal Single Cell Analysis Reveals Hematopoietic Changes across the Human Lifespan
- Research Article
17
- 10.1186/s13287-019-1311-0
- Jul 16, 2019
- Stem Cell Research & Therapy
BackgroundThe paradigm of hematopoietic stem and progenitor cells (HSPCs) has become accepted ever since the discovery of adult mouse liver hematopoietic stem cells and their multipotent characteristics that give rise to all blood cells. However, differences between bone marrow (BM) and liver hematopoietic stem cells and the hematopoietic microenvironment remain poorly understood. In addition, the regulation of the liver hematopoietic system remains unknown.MethodsClone formation assays were used to confirm that the proliferation of adult mouse liver and bone marrow HSPCs. Model mice with different interferon gamma (IFN-γ) levels and a co-culture system were used to detect the differentiation of liver HSPCs. The γ-secretase inhibitor (GSI) and the JAK/STAT inhibitor ruxolitinib and cell culture assays were used to explore the molecular mechanism by which IFN-γ impairs HSPC proliferation and differentiation.ResultsThe colony-forming activity of liver and bone marrow HSPCs was inhibited by IFN-γ. Model mice with different IFN-γ levels showed that the differentiation of liver HSPCs was impaired by IFN-γ. Using a co-culture system comprising liver HSPCs, we found that IFN-γ inhibited the development of liver hematopoietic stem cells into γδT cells. We then demonstrated that IFN-γ might impair liver HSPC differentiation by inhibiting the activation of the notch signaling via the JAK/STAT signaling pathway.ConclusionsIFN-γ inhibited the proliferation of liver-derived HSPCs. IFN-γ also impaired the differentiation of long-term hematopoietic stem cells (LT-HSCs) into short-term hematopoietic stem cells (ST-HSCs) and multipotent progenitors (MPPs) and the process from LSK (Lineage−Sca-1+c-Kit+) cells to γδT cells. Importantly, we proposed that IFN-γ might inhibit the activation of notch signaling through the JAK/STAT signaling pathway and thus impair the differentiation process of mouse adult liver and BM hematopoietic stem cells.
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.